Drawing for Serial No. 79173347

USPTO serial 79173347

Serial No. 79173347

Reviewed by CopyMark Law Group

Reg. 5038411Status 404
Filing date
Status date
Registration date
Sep 13, 2016
Examiner
LEE, DOUGLAS
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 79173347?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Yinfei Wu

Yinfei Wu Hamre, Schumann, Mueller& Larson, P.C.Suite 270045 South Seventh StreetMinneapolis, MN 55402

Goods and services

ClassDescriptionStatusFirst use
005Cod liver oil; Medical tonics for the treatment of menopausal syndrome for women, and used to relieve the symptoms of hot flushes and sweats, restlessness, insomnia, flank pain, dizziness, and tinnitus; royal jelly for medical purposes; Medicines used to diminish inflammation, ease pain, relieve itches, allay a fever, stop bleeding, and reduce swelling; medicinal drinks; Dietary fiber for treating constipation, Dietary fiber to aid digestion, and Dietary fiber for use as an ingredient in the manufacture of dietary supplements; pearl powder for medical purposes; propolis for pharmaceutical purposes; Ginseng electuary for medicinal use; Ginseng for medicinal use; matrimony vine for use as herbal medicines; anaesthetics; Syrups for pharmaceutical purposes, namely, for use in the treatment of a cough; Pharmaceutical preparations for treating skin disorders; Bath salts for medical purposes; medicinal tea; Mentholated ointment for medical use; medical preparations for slimming purposes; By-products of the processing of cereals in the nature of processed oats adapted for medical use; antibiotics; pesticides; douching preparations for medical purposes; personal sexual lubricants; aloe vera preparations for pharmaceutical purposes; teeth filling material; Injectable pharmaceuticals for the treatment of nervous system disorders, immune system disorders, cardio-vascular system disorders, metabolic system disorders, respiratory system disorders, musculo-skeletal system disorders, genitourinary system disorders, inflammatory disorders, gastroenterological disorders, and for use in dermatology, oncology, hematology, ophthalmology; Medicinal preparations in the form of tablets for the treatment of symptoms caused by rheumatism and arthritis; Tincture of iodine; Medicines used to diminish inflammation, ease pain, relieve itches, allay a fever, and reduce swelling; Prepared Chinese medicine for the treatment of nutritional dystrophy, diabetes, obesity, and influenza; Raw material medicine for the treatment of inflammatory disorders; Pharmaceutical preparations relating to biomedicine for the treatment of cervical spondylosis and structural diseases; blood substitutes for medical or veterinary purposes; Encapsulated pills for pharmaceutical purposes for lowering blood pressure, high blood fat and blood sugar, improving eyesight, defecating, and preventing cancer; Alcohol for medicinal purposes; slimming tea for medical purposes; Castor oil for medical purposes; Transdermal patches used to diminish inflammation, ease pain, and reduce swelling; food for babies; Dietetic foods, namely, pasta and crackers adapted for medical use; Dietetic beverages, namely, tea adapted for medical use; air purifying preparations; adhesive tapes for medical purposes; first-aid kits; Chinese medicine sold in bags for use in the treatment of nervous system disorders, immune system disorders, cardio-vascular system disorders, metabolic system disorders, respiratory system disorders, musculo-skeletal system disorders, genitourinary system disorders, inflammatory disorders, gastroenterological disorders, and for use in dermatology, oncology, hematology, ophthalmology; aseptic cotton; Adhesive plasters for medical purposes; Decoctions for pharmaceutical purposes for use in the treatment of nervous system disorders, immune system disorders, cardio-vascular system disorders, metabolic system disorders, respiratory system disorders, musculo-skeletal system disorders, genitourinary system disorders, inflammatory disorders, gastroenterological disorders, and for use in dermatology, oncology, hematology, ophthalmology; sanitary tampons; Disposable paper tissue impregnated with disinfecting chemicals or compounds therefor for use on railings, countertops, and toilet seatsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 12, 2026DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Feb 12, 2026DETHDEATH OF INTERNATIONAL REGISTRATION—
Nov 30, 2025DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Nov 30, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
Jan 7, 2024INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Dec 18, 2023XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Dec 18, 2023XXCRGENERIC MADRID TRANSACTION CREATED—
Nov 24, 2023INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Mar 24, 2023C71TCANCELLED SECTION 71—
Sep 13, 2021REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jun 16, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 2, 2017XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Feb 2, 2017XXCRGENERIC MADRID TRANSACTION CREATED—
Dec 13, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 28, 2016OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Oct 18, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 18, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 13, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 28, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 8, 2016OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 8, 2016OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jun 8, 2016NPUBNOTICE OF PUBLICATION—
May 26, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 9, 2016CNEAEXAMINERS AMENDMENT MAILED—
May 9, 2016XAECEXAMINER'S AMENDMENT ENTERED—
May 9, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
May 6, 2016ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
May 6, 2016PBERWITHDRAWN FROM PUB - EXAMINING ATTORNEY REQUEST—
May 2, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 19, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 18, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 18, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 8, 2015RFNTREFUSAL PROCESSED BY IB—
Oct 16, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 16, 2015RFRRREFUSAL PROCESSED BY MPU—
Oct 10, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 9, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 9, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 5, 2015DOCKASSIGNED TO EXAMINER—
Oct 5, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 1, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance